August 6, 2020
On July 8, 2020, The U.S. Food and Drug Administration (FDA) announced a voluntary recall by Lupin Pharmaceuticals Inc. (Lupin) for all batches of metformin hydrochloride extended release (ER) 500 mg and 1000mg tablets made by their company. The FDA found that certain batches of metformin hydrochloride ER made by Lupin tested higher than the acceptable daily intake limit levels of NDMA.
Members have been asked to contact the pharmacist who dispensed their medication or the provider who prescribed their medication if their medicine is included in this recall. Their pharmacist may dispense another metformin product not affected by this recall and a new prescription isn’t required. Providers may prescribe an alternative treatment option.
Read the FDA announcement on the Lupin recall for more information.